Green + Joint Stock Corp. engages in the manufacture and distribution of pharmaceutical and herbal products. The company was founded in 2016 and is headquartered in Ben Tre, Vietnam.

CSTS Health Care (www.cstshealthcare.com) is a Toronto based biotech founded to create efficacious cancer therapies free from toxic side effects. We are dedicated to improving patient survival and quality of life through our new class of precision oncology agents called Platelet Facilitated Drugs (PFDs). Our novel drug technology, Cytesia, allows delivery of precision drug combinations directly to tumour sites with minimal toxicities, and our proprietary computational biology techniques integrate each patient’s molecular information into a high-fidelity cancer model, drawing upon insights from multiple branches of science and medicine, to provide a rich pipeline of next generation therapies.

Selventa, a personalized healthcare company, provides scientific consulting services, licensed software products, and strategic partnerships for pharmaceutical and biotechnology companies and academic institutions globally. It helps partner companies to develop and optimize pharmaceutical portfolios in various disease areas; analyzes patient data; accelerates the development process; and clarifies decisions on therapeutics and diagnostics. The company engages in short-, mid-, and long-term relationships with pharmaceutical and life science companies to develop new therapeutics and mechanistic biomarkers in the areas of oncology, metabolic disorders, cardiovascular diseases, inflammation, and drug safety. Its solutions also include Hypothesis Investigation Suite, which delivers Project Manager and Project Workbench applications for loading and analyzing large volumes of experiment data using an interactive workbench; Model Investigation Suite offers flash-based applications for viewing, analyzing, and creating explanatory biological models. These analytical software tools are offered to academic, pharmaceutical and biotechnology partners through various hosting options. Selventa was formerly known as Genstruct, Inc. and changed its name to Selventa in November 2010. The company was founded in 2002 and is based in Cambridge, Massachusetts.

Tasly International Gene Network Drug Innovation Center Co., Ltd., established on 2017-06-14, The scope of business includes the research and development of drugs;Import and export of goods and technology;Pharmaceutical Technology Consulting,transfer,Serve.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)***

Researches and analyzes proteins to determine their role in disease

ETRI is the largest government funded research institute in Korea, which strives to advance science by means of formulating innovative ideas; developing new techniques; and training professional individuals in the area of information telecommunications to ultimately enhance social and economical aspects of the modern society.

Shanghai Public Health Clinical Center is a Chinese company located in Shanghai and ultimately controlled by the Government of China that operates hospital and provides education and training for disease control and prevention.

Shanghai Yuanzi Biotechnology Co., Ltd., established on 2017-03-09, Business scope includes general items:engaged in biotechnology,Chemical Technology,Medical Technology,Ecotechnology,New Material Technology,Environmental Technology,Technology development in the field of energy technology,technical consulting,technology transfer,Technical Services,Information Consulting Service(Not including licensing information consulting services);Socioeconomic Advisory Services;Business Management Consulting,Laboratory Instruments and Consumables,Instrumentation,Glass product,ceramics,Rubber products,Chemical Products(No licensed chemical products),recycled resources,Class I medical device,Specialty Chemicals(Free of Hazardous Chemicals)promotion of.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud, and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Dr. Noah Biotech is a pharmaceutical company that develops drugs for orphan disease patients.

Shanghai Qianlong Information Technology Co. Ltd. is a company headquartered in Shanghai, China. The firm provides technology development, consulting and technical services. It was founded in 2014 by Zhi Yun Tu, Qiurui Wang and Liang Yu.

Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient. The company is committed to transforming the way providers prescribe drugs, as well as the way manufacturers, develop new drugs. They are building a molecular map of all protein interactions that identifies genomic signatures and links those to disease and predictive treatment outcomes. Using a simple blood sample to analyze RNA, Scipher Medicine can predict if a patient is likely to respond to a targeted therapy before therapy is prescribed. This insight allows patients to start the most effective therapy from day one. For its first commercial product, they have developed PrismRA®, a first-of-its-kind blood test that can predict which patients with rheumatoid arthritis are less likely to respond to TNFi therapies such as Humira® and Enbrel® so that such patients can go on alternative approved drugs. Scipher Medicine is building the future of patient treatment. Most patients who are prescribed blockbuster therapies today don't respond to treatment, costing the healthcare industry billions in wasted drugs while patients continue to suffer. Scipher's platform identifies which drug will work based on the patient's fundamental disease biology, and not based on symptoms, disease classification, or medical bias. A routine blood test predicts which drug he/she will respond to, with our first product focusing on rheumatoid arthritis, ensuring that the most optimal treatment is prescribed from day one. The molecular data generated by our tests are then used to fuel novel target discovery to address a clear unmet medical need in patients who do not respond to any existing therapy.

IBM United Kingdom Ltd. provides computer software and hardware services. Its products include mainframes, servers, storage systems and peripherals, processors, memory chips, microelectronics and software portfolio with applications from database management tools to operating systems. The company was founded in 1951 and is headquartered in Portsmouth, the United Kingdom.

Second People's Hospital of Nanning (doing business as Nanning No. 2 People's Hospital), part of Guangxi Medical University, is a Chinese company located in Nanning. The firm provides healthcare services.

InSyBio is a biotechnology pioneer company (www.insybio.com) in personalized healthcare and nutrition which focuses on developing computational frameworks and tools for the analysis of complex life-science and biological data. The key objective of our analysis lies in discovering predictive integrated biosignatures (biomarkers of various categories) and models with increased prognostic and diagnostic aspects for personalized Healthcare and Nutrition Industries. Our key products include: -A SaaS platform, InSyBio Suite, for facilitating analysis of biomedical multi-omics data, reducing by 80% time and resources needs for such analysis and raising accuracy of predictive models by at least 10%. -InSyBio Personalization Test which is a tailor-made product for each nutrition company allowing the personalization of nutrition, nutraceutical, vitamin and probiotic products. Since June 2015 InSyBio participates in NBG Business Seeds program by National Bank of Greece and since 2021 InSyBio participates in the Loyal VC program. For more information about our company contact us at info@insybio.com.

Qiming Information Technology is a gene analysis firm specializing in tumor and immunology. It offers solutions for new drug research and clinical application. They provide professional medical research technology in the fields of tumors, immunity, neurobiology, and microbiology.